Cross-Comparison of a Chemiluminescent Platform and a Commercial Receptor Binding Domain-Based ELISA for Detecting SARS-CoV-2 IgG

J Appl Lab Med. 2020 Nov 1;5(6):1416-1420. doi: 10.1093/jalm/jfaa133.

Authors

Thessicar Antoine-Reid¹, James Malone¹, Alexander S Maris¹, Jill White-Abell¹, Jonathan E Schmitz¹

Affiliation

¹ Diagnostic Laboratories and Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN.

No abstract available

Keywords: Abbott Architect; COVID-19; IgG; SARS-CoV-2; Serology.

Publication types

Comparative Study
Evaluation Study
Letter

MeSH terms

Antibodies, Viral / blood
Antibodies, Viral / immunology
Antibodies, Viral / isolation & purification*
Betacoronavirus / immunology
Betacoronavirus / isolation & purification*
COVID-19
COVID-19 Testing
Clinical Laboratory Techniques / instrumentation*
Clinical Laboratory Techniques / statistics & numerical data
Coronavirus Infections / blood
Coronavirus Infections / diagnosis*
Coronavirus Infections / immunology
Coronavirus Infections / virology
Cross Reactions
Enzyme-Linked Immunosorbent Assay / instrumentation
Enzyme-Linked Immunosorbent Assay / statistics & numerical data
False Negative Reactions
Humans
Immunoglobulin G / blood
Immunoglobulin G / immunology
Immunoglobulin G / isolation & purification
Luminescent Measurements / instrumentation
Luminescent Measurements / statistics & numerical data
Pandemics
Pneumonia, Viral / blood
Pneumonia, Viral / diagnosis*
Pneumonia, Viral / immunology
Pneumonia, Viral / virology
Predictive Value of Tests
SARS-CoV-2
Serologic Tests / instrumentation
Serologic Tests / statistics & numerical data

Substances

Antibodies, Viral
Immunoglobulin G